
Amplifon (AMFPF), Babcock (BW), and Constellium (CSTM) have been added to the Zacks Rank #5 (Strong Sell) list following significant downward revisions to their current year earnings estimates. Amplifon's estimates were cut by 8.7%, Babcock's by 10%, and Constellium's by 6.4% over the past 60 days, indicating potential headwinds for these companies and warranting investor caution.
Three companies—Amplifon (AMFPF), Babcock (BW), and Constellium (CSTM)—have been downgraded to a Zacks Rank #5 (Strong Sell), signaling a strongly negative outlook based on deteriorating analyst sentiment. The primary driver for these downgrades is significant downward revisions to their current year consensus earnings estimates over the last 60 days. Babcock, an energy and defense contractor, faced the sharpest revision with a 10% cut to its earnings forecast. Similarly, hearing solutions provider Amplifon saw an 8.7% downward revision, while aluminum products firm Constellium's estimate was lowered by 6.4%. These substantial revisions indicate that analysts foresee considerable headwinds impacting the profitability of these firms, which operate in diverse sectors including healthcare, energy technology, and industrial materials. The negative sentiment is company-specific according to the report, suggesting fundamental challenges at the individual firm level rather than a broad market or single-sector trend.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.75
Ticker Sentiment